Vertigo, a common clinical symptom characterized by the perception of motion where none exists, can be a diagnostic challenge for healthcare professionals. Understanding the pathophysiology and clinical approach to vertigo is paramount to ensure effective patient management.
Vertigo is primarily a manifestation of vestibular dysfunction. It arises from an imbalance in the neuronal activity of the bilateral vestibular nuclei. This can be due to peripheral causes like benign paroxysmal positional vertigo (BPPV), Meniere's disease, or vestibular neuritis, or central causes such as cerebrovascular disease or migraines.
The clinical approach to vertigo begins with a detailed history and physical examination. The temporal pattern of vertigo, associated symptoms like tinnitus or hearing loss, and provoking factors should be thoroughly evaluated. Physical examination should include Dix-Hallpike and head impulse tests.
Basic investigations include complete blood counts, electrolytes, and imaging studies. More specific tests like electronystagmography (ENG), videonystagmography (VNG), or magnetic resonance imaging (MRI) may be necessary based on the clinical suspicion. Audiometric studies can be useful in cases of suspected Meniere's disease.
Management of vertigo depends on the underlying cause. BPPV can be managed with canalith repositioning maneuvers while vestibular suppressants are used for vestibular neuritis. For Meniere's disease, a combination of dietary modification and diuretics is often effective. In refractory cases, vestibular rehabilitation therapy or surgery may be considered.
Vertigo is a complex symptom that requires a comprehensive clinical approach for accurate diagnosis and effective management. A clear understanding of its pathophysiology, clinical presentation, diagnostic investigations, and management strategies will enhance the ability of healthcare professionals to provide optimal patient care.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation